Cargando…
Regulatory T cells mediated immunomodulation during asthma: a therapeutic standpoint
Asthma is an inflammatory disease of the lung airway network, which is initiated and perpetuated by allergen-specific CD4(+) T cells, IgE antibodies, and a massive release of Th2 cytokines. The most common clinical manifestations of asthma progression include airway inflammation, pathological airway...
Autor principal: | Khan, Mohammad Afzal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713035/ https://www.ncbi.nlm.nih.gov/pubmed/33267824 http://dx.doi.org/10.1186/s12967-020-02632-1 |
Ejemplares similares
-
Immunomodulators for Asthma
por: Dimov, Vesselin V, et al.
Publicado: (2010) -
Physical Therapeutics from the Surgical Standpoint
por: Ross, J. Stuart
Publicado: (1921) -
The Prognosis of Asthma from a Digestive Blood Metabolic Etiologic Standpoint
por: Jack, George N.
Publicado: (1905) -
Immunomodulation in Pediatric Asthma
por: Licari, Amelia, et al.
Publicado: (2019) -
The Medical Standpoint
Publicado: (1921)